Featured cases //

In re Nexium Antitrust Litigation
Wexler Wallace LLP, along with its co-counsel, filed a case on behalf of a class of end-payors (i.e., consumers and third-party payors, such as employee benefit funds and insurers) against AstraZeneca for allegedly entering into non-competition agreements with a number of generic pharmaceutical manufacturers in order to delay market entry of generic versions of its blockbuster drug Nexium.
Read more »

Robert Brown, et al. v. Electrolux Home Products, Inc., d/b/a Frigidaire
Wexler Wallace filed a class action lawsuit against Electrolux Home Products, Inc., alleging that certain models of their Frigidaire-branded front-loading washing machines contained a defect which allowed mold, mildew, and “biofilm” to grow inside the machines. The “biofilm” produces a noxious odor that permeates the washing machines, as well as consumers’ clothing and homes. Plaintiffs allege that they and class members have spent money on repairs and other purported remedies, but none have eliminated the odor problems or “biofilm” growth.
Read more »

Featured Investigations //

Zofran
Wexler Wallace LLP is actively pursuing cases against GlaxoSmithKline, the manufacturer of the prescription drug Zofran (Ondansetron). Zofran is an anti-nausea medication approved for use by the FDA to treat nausea post-operatively and in patients undergoing cancer therapy. Though never approved for use during pregnancy, Zofran has been extensively promoted and marketed for off-label use to treat women experiencing morning sickness. Due to this off-label promotion, thousands of women have taken Zofran during their first trimester of pregnancy, an extremely significant time of fetal development.
Read more »

Xarelto Litigation
Xarelto, one of a new class of anticoagulants (blood thinners), has been linked to a large number of injuries requiring hospitalizations with some resulting in deaths. Like all blood thinners, Xarelto can cause serious internal bleeding in some. Xarelto bleeding is difficult to stop, as there is currently no known reversal agent for this occurrence, therefore hemorrhaging will continue until the drug is cleared from the system. Wexler Wallace LLP is providing case evaluations for individuals who may have been injured while taking Xarelto.
Read more »

Recent Blog Posts //

A Setback for Generic Consumers
05/21/2015
The road to recovery for generic drug consumers just got more difficult. After a series of rulings from the U.S. Supreme Court over the past few years, a person
Read more »

Fairness in Class Action Bill Does Not Live Up to Its Name
04/28/2015
Last week, House Judiciary Committee Chairman Bob Goodlatte (R-Va.) and Constitution and Civil Justice Subcommittee Chairman Trent Franks (R-Ariz.) introduced t
Read more »

E-Cigarettes: The New Kink in the Fight Against Tobacco
04/22/2015
While the anti-tobacco movement has made major legislative strides over the years in the fight against death and disease caused by cigarette smoking and other t
Read more »